Clinical trial · Interventional
Radiofrequency Ablation in Treating Patients With Refractory or Advanced Lung Cancer
Radiofrequency Ablation of Pulmonary Malignancy
NCT00024076CI-TRIAL-00046362completedPhase 2ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
RATIONALE: Radiofrequency ablation uses high-frequency electric current to kill tumor cells. CT-guided radiofrequency ablation may be effective treatment for lung cancer. PURPOSE: Phase II trial to study the effectiveness of radiofrequency ablation in treating patients who have refractory or advanced lung cancer.
Conditions
Conditions (4)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Lung Cancer | Malignant Lung Neoplasm | CURATED_EXACT | 0.92 |
| Malignant Mesothelioma | Malignant Mesothelioma | ONTOLOGY_EXACT | 0.98 |
| Metastatic Cancer | Malignant Neoplasm | CURATED_BROADER | 0.78 |
| Thymoma and Thymic Carcinoma | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| radiofrequency ablation | Procedure | — | UNRESOLVED |
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * Diagnosis of a primary or secondary intrathoracic malignancy * Any cell type or origin * Involving the intrapulmonary, mediastinal, or pleural/chest wall * Inoperable primary or metastatic cancer to the lung * Refractory to or not amenable to conventional therapy (e.g., surgery, chemotherapy, or radiotherapy) * Single or multiple lesions that are non-contiguous with vital structures or organs such as: * Trachea * Heart * Aorta * Great vessels * Esophagus * Less than 5 cm in largest dimension * Accessible via percutaneous transthoracic route * Hepatic: * Coagulation profile normal
References
Publications (0)
Data not yet available
No reference posted for this study.